VistaGen Therapeutics Inc (NASDAQ:VTGN)
| 2.81 BATS BZX Real-Time Price As of 2:26pm ET |  -0.17 / -5.70%Today’s Change | 0.56 Today|||52-Week Range 3.55 | +44.85% Year-to-Date |
Latest VTGN News | Press Releases
No recent news for VistaGen Therapeutics Inc.
Today’s Trading
| Previous close | 2.98 |
| Today’s open | 2.92 |
| Day’s range | 2.81 - 2.98 |
| Volume | 24,472 |
| Average volume (3 months) | 2,282,503 |
| Market cap | $574.9M |
Data as of 2:26pm ET, 09/20/2021
Growth & Valuation
| Earnings growth (last year) | +2.19% |
| Earnings growth (this year) | +51.53% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | 168.39 |
| Price/Book | 5.85 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| EPZMEpizyme Inc | -0.26 | -4.54% |
| CGENCompugen Ltd | -0.51 | -7.62% |
| MGTXMeiraGTx Holdings PL... | -0.74 | -5.50% |
| RDUSRadius Health Inc | -0.62 | -4.84% |
Data as of 2:33pm ET, 09/20/2021
Financials
| Next reporting date | November 11, 2021 |
| EPS forecast (this quarter) | -$0.06 |
| Annual revenue (last year) | $1.1M |
| Annual profit (last year) | -$17.9M |
| Net profit margin | -1,646.09% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters South San Francisco, California |
Forecasts
